Tower Research Capital LLC (TRC) - ELIEM THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ELIEM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,246
-23.0%
3,896
-18.0%
0.00%
Q2 2023$13,311
+147800.0%
4,754
+45.7%
0.00%
Q1 2023$9
+350.0%
3,262
+408.1%
0.00%
Q4 2022$2
-99.9%
642
-34.6%
0.00%
Q3 2022$3,000
+200.0%
981
+123.0%
0.00%
Q2 2022$1,000
-95.0%
440
-81.9%
0.00%
Q1 2022$20,000
+100.0%
2,431
+142.9%
0.00%
Q4 2021$10,000
+11.1%
1,001
+103.9%
0.00%
Q3 2021$9,0004910.00%
Other shareholders
ELIEM THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,583,170$4,432,8763.99%
RA Capital Management 13,150,849$36,822,3770.70%
SILVERARC CAPITAL MANAGEMENT, LLC 494,089$1,383,4490.43%
Atom Investors LP 78,886$220,8810.08%
DRIEHAUS CAPITAL MANAGEMENT LLC 810,593$2,269,6600.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 55,223$154,6240.00%
Chicago Partners Investment Group LLC 16,570$45,7330.00%
TWO SIGMA SECURITIES, LLC 14,279$39,9810.00%
TUDOR INVESTMENT CORP ET AL 29,706$83,1770.00%
NORTHERN TRUST CORP 11,182$31,3100.00%
View complete list of ELIEM THERAPEUTICS INC shareholders